Eye Diseases Completed Phase 1 / 2 Trials for Ranibizumab (DB01270)

IndicationStatusPhase
DBCOND0030511 (Eye Diseases)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01746563Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic RetinopathyTreatment